Search by Drug Name or NDC

    NDC 41250-0728-62 12 hour allergy d 5; 120 mg/1; mg/1 Details

    12 hour allergy d 5; 120 mg/1; mg/1

    12 hour allergy d is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Meijer Distribution Inc. The primary component is CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 41250-0728
    Product ID 41250-728_431b0861-e653-4a2d-8721-408cf9fdb842
    Associated GPIs 43993002277420
    GCN Sequence Number 048415
    GCN Sequence Number Description cetirizine HCl/pseudoephedrine TAB ER 12H 5 MG-120MG ORAL
    HIC3 Z2O
    HIC3 Description 2ND GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 13866
    HICL Sequence Number 022864
    HICL Sequence Number Description CETIRIZINE HCL/PSEUDOEPHEDRINE HCL
    Brand/Generic Generic
    Proprietary Name 12 hour allergy d
    Proprietary Name Suffix n/a
    Non-Proprietary Name cetirizine hydrochloride, pseudoephedrine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 5; 120
    Active Ingredient Units mg/1; mg/1
    Substance Name CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name Meijer Distribution Inc
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210719
    Listing Certified Through 2024-12-31

    Package

    NDC 41250-0728-62 (41250072862)

    NDC Package Code 41250-728-62
    Billing NDC 41250072862
    Package 24 BLISTER PACK in 1 CARTON (41250-728-62) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2020-04-07
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL b7019ea1-ca3d-4ddb-8cf4-e4ca7cb95e77 Details

    Revised: 9/2020